Literature DB >> 8595853

Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection.

F J Lacroix1, A Cloeckaert, O Grépinet, C Pinault, M Y Popoff, H Waxin, P Pardon.   

Abstract

Salmonella serotype typhimurium transpositional mutants altered in resistance to biliary salts and detergents were isolated previously. We have characterized further the LX1054 mutant strain, the most sensitive of them. The chromosomal DNA segment flanking transposon insertion was cloned and sequenced. The highest level of identity was found for the acrB (formerly acrE) gene of Escherichia coli, a gene encoding a drug efflux pump of the Acr family. LX1054 exhibited a reduced capacity to colonize the intestinal tract. After passages in mice, the mutant strain lost the sensitive phenotype. In vitro, a resumption of growth appeared after 17 h of culture in medium with cholate or other tested biological or chemical detergents. Then, the acquired resistant phenotype seemed stable. The data suggested a role of S. typhimurium acrB-like gene in resistance to biliary salts and detergents and in mice intestinal colonization. However, the local and transient sensitivity observed in vivo, and the in vitro adaptations suggest that several detergent-resistance mechanisms operate in S. typhimurium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8595853     DOI: 10.1111/j.1574-6968.1996.tb07983.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  40 in total

1.  Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium.

Authors:  L J Piddock; D G White; K Gensberg; L Pumbwe; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 2.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 3.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 4.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 5.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC.

Authors:  Vito Ricci; Peter Tzakas; Anthony Buckley; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

7.  Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Julianne V Kus; Ahferom Gebremedhin; Vica Dang; Seav-Ly Tran; Anca Serbanescu; Debora Barnett Foster
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

Review 8.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains.

Authors:  H Nikaido; M Basina; V Nguyen; E Y Rosenberg
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

10.  Robustness analysis of culturing perturbations on Escherichia coli colony biofilm beta-lactam and aminoglycoside antibiotic tolerance.

Authors:  Trevor R Zuroff; Hans Bernstein; Jenna Lloyd-Randolfi; Lourdes Jimenez-Taracido; Philip S Stewart; Ross P Carlson
Journal:  BMC Microbiol       Date:  2010-07-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.